Results 191 to 200 of about 171,882 (296)

Artificial-intelligence-enabled digital stethoscope improves point-of-care screening for moderate-to-severe valvular heart disease. [PDF]

Eur Heart J Digit Health
Rancier M, Israel I, Monickam V, Currie C, Verschoore B, Lastowski E, Van Pelt DW, Prince J, McDonough RV.   +8 more
europepmc   +1 more source

The use of multimodality imaging in infective endocarditis diagnosis

Cardiology Journal
Michał Wrzosek, Karina Zatorska, Anna Konopka, Małgorzata Pastuszek-Tyc, Paweł Litwiński, Piotr Trochimiuk, Tomasz Hryniewiecki, Ilona Michałowska   +7 more
doaj   +1 more source

Potential Diagnostic Value of Circular RNA hsa_circ_0008882 in Rheumatic Valvular Heart Disease. [PDF]

Int J Gen Med
Hu Y, Li N, Sun L, Shi H, Shao G, Zhu L.
europepmc   +1 more source

Comprehensive Nursing Management of Anticoagulation and Heart Failure Surveillance in a Chinese Patient With Mirror‐Image Dextrocardia Post‐MitraClip Surgery: A First Case Report

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mitral regurgitation (MR) is the valent type of valvular heart disease, caused by primary leaflet lesions or annular dilatation secondary to left ventricular dysfunction. It can lead to a series of complications such as volume overload, exacerbated pulmonary congestion, and heart failure, significantly impacting patient prognosis ...
Juelian Li, Chun Wu, Chao Shang, Yu Deng, Jinxia Zhang   +4 more
wiley   +1 more source

Future of Valvular Heart Disease and Structural Heart Interventions: Why So Much Excitement? [PDF]

J Pers Med
Beneki E, Grapsa J.
europepmc   +1 more source

Mitral Transcatheter Edge‐to‐Edge Repair in Patients With Advanced Heart Failure: A Single‐Center Experience and Insights Into Anatomical and Clinical Determinants of Procedural Complexity

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Advanced heart failure (HF) remains a clinical challenge, and mitral transcatheter edge‐to‐edge repair (M‐TEER) has emerged as a potential bridging strategy. Aims To describe the clinical outcomes of M‐TEER in a single‐center cohort of patients with advanced HF and to identify anatomical and clinical features potentially associated ...
Pedro Castilhos de Freitas Crivelaro, Laura Hastenteufel, Guilherme Pinheiro Machado, Felipe Fuchs, Antonio Pinotti, Marco Vugman Wainstein, Nadine Clausell, Lívia Adams Goldraich, Felipe Homem Valle   +8 more
wiley   +1 more source

Rational and design of EACVI-MMVD study: an international registry on multimodality imaging for mixed and multiple valvular heart disease. [PDF]

Eur Heart J Imaging Methods Pract
Unger A, Mandoli GE, Neglia D, Romero Dorta E, Kagiyama N, Borodzicz-Jazdzyk S, Velegraki E, Coisne A, Uygur B, Afana A, Florence J, Bohbot Y, Donal E, Clavel MA, Pibarot P, Unger P, Manka R, Nijveldt R, Gimelli A, Gerber B, Dweck M, Muraru D, Pontone G, Ajmone Marsan N, Timoteo AT, Toupin S, Pereira C, Cosyns B, Vicaut E, Delgado V, Petersen S, Pezel T.   +31 more
europepmc   +1 more source

Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?

Clinical Pharmacology &Therapeutics, EarlyView.
Pediatric drug development has achieved remarkable success in the last 20 years with over 1,000 products studied in pediatric patients. This success has been driven in part by an increased understanding of pediatric disease processes. The aspect that has been largely overlooked is the potential adverse effect of new drugs on pediatric developmental ...
Gilbert J. Burckart, Susan M. Abdel‐Rahman, Gelareh Abulwerdi, Sherbet Samuels, Rebecca Racz, Mohamed A. Mohamoud, Nicholas P. Tatonetti   +6 more
wiley   +1 more source

Burden of Valvular Heart Disease Diagnosed on Protocolised Echocardiography for Waitlist Placement in End-Stage Kidney Patients. [PDF]

Nephrology (Carlton)
Ho QY, Wong N, Liew IT, Tien CS, Lye YN, Chen H, Ong SZH, Tan JQ, Lee CY, Thangaraju S, Keh YS, Yeo KK, Chua TSJ, Kee T.   +13 more
europepmc   +1 more source

Implementation of OMOP and ConcePTION Common Data Models in CPRD GOLD: Risk of Bleeding and Cardiovascular Outcomes From Anticoagulant Use

Clinical Pharmacology &Therapeutics, EarlyView.
The impact of the choice of common data model (CDM) approach on the study results in a real‐world evidence (RWE) study is unknown. We aimed to determine potential differences in the results of an RWE study when data were mapped to two different CDMs, ConcePTION and OMOP. With the same instance of CPRD GOLD, data were mapped to both CDMs. Using the same
Nicholas B. Hunt, Patrick Souverein, Marloes Bazelier, Nicola Barclay, Antonella Delmestri, Miriam Sturkenboom, Daniel Prieto‐Alhambra, Helga Gardarsdottir, Olaf Klungel   +8 more
wiley   +1 more source